We are enrolling volunteers aged 55 or over who struggle with falling or staying asleep as well as waking up at night to urinate for our latest insomnia and nocturia research study.
Recruiting Now
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
Accellacare offers research participation options for those with MS such as; advancing current treatments, finding new therapies, and addressing associated symptoms.
Accellacare is enrolling a research study evaluating an investigational medication for Parkinson's disease. Eligible participants will receive study-related care and study medication at no cost.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling a research study evaluating an investigational medication for agitation associated with Alzheimer's disease. Eligible participants will receive study-related care and study medication at no cost.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling adults who display COVID-19 symptoms, but are not at risk for severe illness. Eligible participants will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling a research study for current e-cigarettes, vape, Juul, e-pen users to evaluate an ENDS. Eligible participants will receive financial compensation of for time and travel and access to ENDS for the duration of the study.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Patient Resources
The Patient Voice
Accellacare saw a need for a patient feedback and engagement program that gives patients a voice directly to the industry, to help create a truly patient-centric clinical research environment. The answer was The Patient Voice program.
Lunch and Learn
with Friends
Treat yourself and a friend to a free lunch that may positively impact their health.
Tell a Friend
Know someone who may benefit from research participation? Provide your referrals* below and we will contact them about their volunteer options. If they qualify, you will receive a gift card as a thank you.
News & Insights:
Developing vaccines started over 200 years ago when Dr. Edward Jenner created the first vaccine designed to immunize against smallpox. In 1980, the World Health Organization (WHO) determined that smallpox, a disease that killed over 35% of its victims, was eradicated worldwide.
World Parkinson’s Day is celebrated on the 11th of April each year and it’s a day set aside to raise awareness of the reality of Parkinson’s disease and how it affects individuals and their families.
Nothing excites us more than talking with one of our patients. We asked retired Obstetrician Dr. Michael Hoffman, who participated in an RSV vaccine study, to answer a few questions for us. This is what he had to say.
